Newsletter
Newsletter

Diagnosing X-Linked Retinoschisis (XLRS)

by | Apr 12, 2018

David G. Birch, PhD, Chief Scientific and Executive Officer and Director of the Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest discusses how Optometrists and Ophthalmologists typically diagnose X-linked retinoschisis (XLRS)....

NIH Publishes Genomic Analysis of 33 Cancer Types

by | Apr 12, 2018

National Institutes of Health (NIH) funded researchers completed a genomic analysis, known as the PanCancer Atlas, on a data set of molecular and clinical information from over 10,000 tumors representing 33 types of cancer. “This project is the culmination of more...

Upcoming Milestones for Spark Therapeutics

by | Apr 12, 2018

  Jeff Marrazzo, Co-Founder and CEO of Spark Therapeutics, discusses upcoming milestones in 2018 for his company, including plans to begin a program in Pompe disease. Spark is advancing research programs against cell targets in the retina, liver and central...

NIH Team Confirms New Genetic Mutation Link to ALS

by | Apr 10, 2018

Kinesin family member 5A (KIF5A), a gene previously linked to two rare neurodegenerative disorders, has been definitively connected to amyotrophic lateral sclerosis (ALS) by an international team from several of the world’s top ALS research labs. The findings identify...